pharma-company /Medicinal products /Active ingredients

Rx · PZN 15023863

OGIVRI 150 mg powder for a concentrate for preparation of a solution for infusion

German trade nameOGIVRI 150 mg Pulver für einer Konzentrat zur Herstellung einer Infusionslösung

Active ingredientTrastuzumab

Available with fluctuations

3.9

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €623

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for OGIVRI 150 mg powder for a concentrate for preparation of a solution for infusion.

Review purchasing terms

OGIVRI 150 mg powder for a concentrate for preparation of a solution for infusion contains the active ingredient Trastuzumab. One pack size is recorded (PZN 15023863). The pharma availability index for German wholesale stands at 3.9 out of 10 over the past 30 days – the pack was therefore available with fluctuations.


Availability of OGIVRI 150 mg powder for a concentrate for preparation of a solution for infusion fluctuates noticeably. We are happy to advise you on securing your supply through additional sources.

Secure your supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.